NCT07698288

Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions

CompletedNAINTERVENTIONAL

Trial Details

Start: 2026-02-12Est. Completion: 2026-04-16

Enrollment target: 66 participants

Locations

CetuximabBioequivalenceHealthy VolunteersPharmacokinetics

A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection …

Haikou, ChinaEst. completion Jun 30, 2027

Healthy Volunteers

The main aim is to see how soticlestat tablets of different strengths work and to compare how it works alone in contrast…

Tempe, United StatesCompleted May 22, 2022

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.